Linxi Zhu, Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, & Rodney J. Y. Ho. (2021). ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. MDPI AG.
Chicago Style (17th ed.) CitationLinxi Zhu, Qingxin Mu, Jesse Yu, James I. Griffin, Xiaolin Xu, and Rodney J. Y. Ho. ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. MDPI AG, 2021.
MLA (9th ed.) CitationLinxi Zhu, et al. ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.